The global Rapid Antigen Testing market is expanding as healthcare providers, diagnostic laboratories, and consumers invest in advanced diagnostic solutions to address the rising incidence of infectious diseases and improve patient outcomes. The market was valued at USD 2.4 billion in 2024 and is projected to reach USD 6.8 billion by 2035, growing at a CAGR of 9.9%.
The Rapid Antigen...